Loading song details...
GDF 2024 D2S02 GDSA BE Modernizing Bioequivalence Assessment For Abbreviated New Drug
No description available.
MP3 Download
Video Download
Related Songs
16:44
GDF 2024 D2S02 GDSA BE Modernizing Bioequivalence Assessment For Abbreviated New Drug
22:52
GDF 2024 D2S01 Pediatric Excipient Evaluation BE Perspective
8:11:48
Generic Drugs Forum GDF 2026 Day 2
23:28
GDF 2024 D2S10 ANDA Submission Risk Based Extractable And Leachable Quality Information
21:09
GDF 2024 D2S06 Nitrosamine Risk Assessment In Type II DMFs Supporting GDUFA Applications
17:44
GDF 2024 D2S17 Regulatory Reminders To The Finish Line
21:11
GDF 2024 D2S08 Quality Considerations For Topical Ophthalmic Drug Products Guidance
25:04
GDF 2024 D2S07 Post Approval Changes In Complex Generics From Drug Product CMC Perspectives
12:19
GDF 2024 D2S03 2 Comparative Analyses Update
16:20
GDF 2024 D2S11 2 GDUFA III Implementation Facility Related Updates
32:15
GDF 2024 D2S05 Q A Discussion Panel 1
16:26
GDF 2024 D1S02 Office Of Generic Drugs Keynote Collaboration And Tools For Success
2:50
Gen Amrhein CMSgt Arbona ID2A 2024
14:30
GDF 2024 D2S16 ANDAs Labeling Requirements For Rx To OTC Switched Products
21:33
GDF 2024 D1S07 Overview Of The FDA Product Specific Guidance PSG Program
12:59
GDF 2024 D2S12 ETP And AMTDP Which Program Is Right For Me
19:09
GDF 2024 D1S11 Overview And Considerations Of Pre ANDA Scientific Meetings Under GDUFA III
1:26:21
Generic Drugs Forum GDF 2024 Regulatory Considerations To Enhance Drug Access Day 2 Pt
28:09
GDF 2024 D1S05 Policy Accomplishments
8:15:13